Fig. 3 | Modern Pathology

Fig. 3

From: Impact of TP53 immunohistochemistry on the histological grading system for endometrial endometrioid carcinoma

Fig. 3

Stratification according to age, histological grade, and TP53 status. a The ratio (%) of TP53 status for each 5-year interval in each histological grade and b the ratio (%) of TP53 status based on a cutoff value of 60 years. c Stratification according to histological grade, age, and TP53 status. d Schema of the prognostic grading system. G1/2 with TP53-normal expression was reclassified as low-grade endometrial endometrioid carcinoma, and G1/2 with TP53-aberrant expression plus G3 (TP53-normal or -aberrant expression) were reclassified as high-grade endometrial endometrioid carcinoma

Back to article page